Balchem Corporation (BCPC)

Market Cap	4.14B
Revenue (ttm)	922.96M
Net Income (ttm)	108.91M
Shares Out	32.14M
EPS (ttm)	3.35
PE Ratio	38.47
Forward PE	31.55
Dividend	$0.71 (0.55%)
Ex-Dividend Date	Dec 23, 2022

Volume	65,545
Open	128.72
Previous Close	129.37
Day's Range	127.46 - 130.05
52-Week Range	110.15 - 148.05
Beta	0.69
Analysts	Buy
Price Target	158.78 (+23.2%)
Earnings Date	Feb 17, 2023

About BCPC

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and ...

• Industry: Specialty Chemicals
• Sector: Materials
• CEO: Theodore Harris
• Employees: 1,382
• Stock Exchange: NASDAQ
• Ticker Symbol: BCPC

Financial Performance

In 2021, Balchem's revenue was $799.02 million, an increase of 13.56% compared to the previous year's $703.64 million. Earnings were $96.10 million, an increase of 13.57%.

Analyst Forecast

According to 9 analysts, the average rating for BCPC stock is "Buy." The 12-month stock price forecast is $158.78, which is an increase of 23.20% from the latest price.

Price Target

$158.78

(23.20% upside)

Analyst Consensus: Buy